✦ LIBER ✦

246 ASSESSMENT OF PAROXETINE IN THE PREVENTION OF DEPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C TREATED BY PEG-INTERFERON-RIBAVIRIN.: A DOUBLE-BLINDED, RANDOMIZED STUDY. ANRS HC18 PAROPEG

✍ Scribed by J.-P. Bronowicki; V. Canva; A. Tran; M.-N. Hilleret; S. Pol; M. Mainard; M. Bourlière; V. de Ledinghen; A. Abergel; K. Barange; N. Ganne; P. Cales; V. Di Martino; O. Goria; J.-M. Molina; L. Alric; J.-J. Raabe

Book ID: 117378332
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 52 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(10)60248-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

536 Assessment of Paroxetine in the Prev

536 Assessment of Paroxetine in the Prevention of Depression in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alpha Plus Ribavirin: A Multicentric, Double-Blinded, Randomized Study. ANRS HC18 Paropeg

✍ Bronowicki, Jean-Pierre; Canva, Valerie; Tran, Albert; Hilleret, Marie-Noelle; P 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 88 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB